Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9OGW

Identification of ligands for E3 ligases using fragment-based methods

This is a non-PDB format compatible entry.
Summary for 9OGW
Entry DOI10.2210/pdb9ogw/pdb
DescriptorE3 ubiquitin-protein ligase CBL-C, 2-{[(thiophen-3-yl)methyl]amino}benzoic acid (3 entities in total)
Functional Keywordssmall molecule, complex crystal structure, cbl-c, tkb (tyrosine kinase binding), regulator of egfr mediated signal transduction, ligase
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight35695.93
Authors
Phan, J.,Fesik, S.W. (deposition date: 2025-05-02, release date: 2025-10-22, Last modification date: 2025-11-05)
Primary citationWaterson, A.G.,Lehmann, B.D.,Lu, Z.,Sensintaffar, J.L.,Olejniczak, E.T.,Zhao, B.,Rietz, T.,Payne, W.G.,Phan, J.,Fesik, S.W.
Identification of ligands for E3 ligases with restricted expression using fragment-based methods.
Rsc Chem Biol, 6:1797-1808, 2025
Cited by
PubMed Abstract: Heterobifunctional molecules that induce targeted degradation have emerged as powerful tools in chemical biology, target validation, and drug discovery. Despite their promise, the field is constrained by the relative paucity of ligands available for E3 ligases. Expanding the ligand repertoire for E3 ligases and other components of ubiquitin-proteasome system could significantly broaden the scope of the targeted degradation field. In this study, we report the identification of ligands for non-essential E3 ligases that are preferentially expressed in cancer tissues relative to normal tissues. Using a protein-observed NMR-based fragment screen, an ideal technique for this purpose, we identified fragment ligands and characterized their binding modes by X-ray crystallography. These ligands represent promising starting points for further optimization toward the discovery of tumor-selective degraders that may enhance the therapeutic window targeting proteins for which inhibition or degradation is associated with systemic toxicity.
PubMed: 41070186
DOI: 10.1039/d5cb00198f
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

246031

数据于2025-12-10公开中

PDB statisticsPDBj update infoContact PDBjnumon